Bristol-Myers Squibb Co. (BMY) Tops Q3 EPS by 3c; Narrows FY11 Guidance
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.61, $0.03 better than the analyst estimate of $0.58. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.3 billion.
Bristol-Myers Squibb Co. sees FY2011 EPS of $2.25-$2.30, versus prior guidance of $2.20-$2.30 and the consensus of $2.8.
Bristol-Myers Squibb Co. sees FY2011 EPS of $2.25-$2.30, versus prior guidance of $2.20-$2.30 and the consensus of $2.8.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- JD.com earnings preview: stronger profit expected, macro headwinds in focus
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
